Most active investors · All time

Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.

Browse by month

301

Logos CapitalLatest Apr 14

Adcendo · $75M Series C Mirador Therapeutics · $250M Series B

2rounds

—led

Biotech 2

Series B 1, Series C+ 1

Apr 14, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Adcendo $75M Series C Mirador Therapeutics $250M Series B

302

Beijing Medical and Health Care Industry Investment FundLatest Apr 9

Oricell Therapeutics · $110M Pre-IPO Oricell Therapeutics · $70M Series C1

2rounds

—led

Biotech 2

Series C+ 1, Undisclosed 1

Apr 9, 2026

Details

New companies 1 · Follow-on 1

Stages: Series C+ 1, Undisclosed 1

Oricell Therapeutics $110M Pre-IPO Oricell Therapeutics $70M Series C1

303

E-Town CapitalLatest Apr 9

Oricell Therapeutics · $110M Pre-IPO Oricell Therapeutics · $70M Series C1

2rounds

—led

Biotech 2

Series C+ 1, Undisclosed 1

Apr 9, 2026

Details

New companies 1 · Follow-on 1

Stages: Series C+ 1, Undisclosed 1

Oricell Therapeutics $110M Pre-IPO Oricell Therapeutics $70M Series C1

304

NGS SuperLatest Apr 9

Oricell Therapeutics · $110M Pre-IPO Cauldron Ferm · $13.3M Series A2

2rounds

—led

Biotech 2

Series A 1, Undisclosed 1

Apr 9, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Undisclosed 1

Oricell Therapeutics $110M Pre-IPO Cauldron Ferm $13.3M Series A2

305

Talon CapitalLatest Apr 9

Oricell Therapeutics · $110M Pre-IPO Oricell Therapeutics · $70M Series C1

2rounds

—led

Biotech 2

Series C+ 1, Undisclosed 1

Apr 9, 2026

Details

New companies 1 · Follow-on 1

Stages: Series C+ 1, Undisclosed 1

Oricell Therapeutics $110M Pre-IPO Oricell Therapeutics $70M Series C1

306

Goldman Sachs Alternatives Life SciencesLatest Apr 8

Sidewinder Therapeutics · $137M Series B Third Arc Bio · $52M Series A+

2rounds

—led

Biotech 2

Series A 1, Series B 1

Apr 8, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Sidewinder Therapeutics $137M Series B Third Arc Bio $52M Series A+

307

Blue Owl Healthcare OpportunitiesLatest Mar 31

Ambrosia Biosciences · $100M Series B Mirador Therapeutics · $250M Series B

2rounds

1led

Biotech 2

Series B 2

Mar 31, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

Ambrosia Biosciences $100M Series B Mirador Therapeutics $250M Series B

308

BVF PartnersLatest Mar 31

Ambrosia Biosciences · $100M Series B Crossbow Therapeutics · $77M Series B

2rounds

0led

Biotech 2

Series B 2

Mar 31, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

Ambrosia Biosciences $100M Series B Crossbow Therapeutics $77M Series B

309

TLV PartnersLatest Mar 31

Scala Biodesign · $16M Series A Converge Bio · $25M Series A

2rounds

—led

AI 1Biotech 1

Series A 2

Mar 31, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 2

Scala Biodesign $16M Series A Converge Bio $25M Series A

310

ExtantiaLatest Mar 25

Epoch Biodesign · $12M Strategic Renasens · €10M Seed

2rounds

—led

Climate tech 2

Seed 1, Undisclosed 1

Mar 25, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Undisclosed 1

Epoch Biodesign $12M Strategic Renasens €10M Seed

311

Amplitude VenturesLatest Mar 19

Congruence Therapeutics · $39.5M Series B Mediar Therapeutics · $76M Series B

2rounds

—led

Biotech 2

Series B 2

Mar 19, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

Congruence Therapeutics $39.5M Series B Mediar Therapeutics $76M Series B

312

Nina CapitalLatest Mar 18

Rivia · $15M Series A Navidence · Undisclosed Seed

2rounds

—led

Healthtech 2

Seed 1, Series A 1

Mar 18, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series A 1

Rivia $15M Series A Navidence Undisclosed Seed

313

General InceptionLatest Mar 17

Surf Therapeutics · $6M Seed Resolve M Therapeutics · Undisclosed Undisclosed

2rounds

—led

Biotech 1Healthtech 1

Seed 1, Undisclosed 1

Mar 17, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Undisclosed 1

Surf Therapeutics $6M Seed Resolve M Therapeutics Undisclosed Undisclosed

314

SparkfoodLatest Mar 17

Sequential · $3.5M Seed Verley · €32M Series A

2rounds

—led

Foodtech 1Healthtech 1

Seed 1, Series A 1

Mar 17, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series A 1

Sequential $3.5M Seed Verley €32M Series A

315

Understorey VenturesLatest Mar 17

Rubi · $7.5M Undisclosed Transition Metal Solutions · $6M Seed

2rounds

—led

Climate tech 1Industrial tech 1

Seed 1, Undisclosed 1

Mar 17, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Undisclosed 1

Rubi $7.5M Undisclosed Transition Metal Solutions $6M Seed

316

AIX VenturesLatest Mar 10

Unreasonable Labs · $13.5M Seed Proxima · $80M Undisclosed

2rounds

—led

AI 1Biotech 1

Seed 1, Undisclosed 1

Mar 10, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Undisclosed 1

Unreasonable Labs $13.5M Seed Proxima $80M Undisclosed

317

Cencora VenturesLatest Mar 5

NexCure · $19M Series A RISA Labs · $11.1M Series A

2rounds

—led

AI 1Healthtech 1

Series A 2

Mar 5, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 2

NexCure $19M Series A RISA Labs $11.1M Series A

318

Nucleus CapitalLatest Mar 3

Bindbridge · $3.8M Seed Biographica · £7M Undisclosed

2rounds

—led

Agritech 2

Seed 1, Undisclosed 1

Mar 3, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Undisclosed 1

Bindbridge $3.8M Seed Biographica £7M Undisclosed

319

Soulmates VenturesLatest Mar 3

Antiverse · $9.3M Series A FluoSphera · €1.2M Undisclosed

2rounds

1led

Biotech 1Healthtech 1

Series A 1, Undisclosed 1

Mar 3, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Undisclosed 1

Antiverse $9.3M Series A FluoSphera €1.2M Undisclosed

320

DAYLI PartnersLatest Feb 25

BreezeBio · $60M Series B Galux · $29M Series B

2rounds

—led

Biotech 2

Series B 2

Feb 25, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

BreezeBio $60M Series B Galux $29M Series B

321

Pathway InvestmentLatest Feb 25

BreezeBio · $60M Series B Galux · $29M Series B

2rounds

—led

Biotech 2

Series B 2

Feb 25, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

BreezeBio $60M Series B Galux $29M Series B

322

Yuanta InvestmentLatest Feb 25

BreezeBio · $60M Series B Galux · $29M Series B

2rounds

—led

Biotech 2

Series B 2

Feb 25, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

BreezeBio $60M Series B Galux $29M Series B

323

FairmountLatest Feb 18

Korsana Biosciences · $175M Series A Mirador Therapeutics · $250M Series B

2rounds

—led

Biotech 2

Series A 1, Series B 1

Feb 18, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Korsana Biosciences $175M Series A Mirador Therapeutics $250M Series B

324

Entrepreneurs FirstLatest Jan 29

Automata · $45M Series C Biographica · £7M Undisclosed

2rounds

—led

Agritech 1Industrial tech 1

Series C+ 1, Undisclosed 1

Jan 29, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 1, Undisclosed 1

Automata $45M Series C Biographica £7M Undisclosed

325

Global Health Investment Corporation (GHIC)Latest Jan 29

Prenosis · $20M Series A Antheia · $24M Series C second close

2rounds

0led

Biotech 2

Series A 1, Series C+ 1

Jan 29, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

Prenosis $20M Series A Antheia $24M Series C second close

326

Octopus VenturesLatest Jan 29

Automata · $45M Series C Infinitopes · $15.4M Seed

2rounds

—led

Biotech 1Industrial tech 1

Seed 1, Series C+ 1

Jan 29, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series C+ 1

Automata $45M Series C Infinitopes $15.4M Seed

327

Willett AdvisorsLatest Jan 28

Cellares · $257M Series D Kinaset Therapeutics · $103M Series B

2rounds

—led

Biotech 2

Series B 1, Series C+ 1

Jan 28, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Cellares $257M Series D Kinaset Therapeutics $103M Series B

328

Delos CapitalLatest Jan 27

TRex Bio · $50M Undisclosed STRM.BIO · $8M Seed2

2rounds

—led

Biotech 2

Seed 1, Undisclosed 1

Jan 27, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Undisclosed 1

TRex Bio $50M Undisclosed STRM.BIO $8M Seed2

329

GimvLatest Jan 20

Exciva · €51M Series B Kinaset Therapeutics · $103M Series B

2rounds

—led

Biotech 2

Series B 2

Jan 20, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

Exciva €51M Series B Kinaset Therapeutics $103M Series B

330

CAZ InvestmentsLatest Oct 22

Warhound · $200M Seed

1rounds

0led

Defense tech 1

Seed 1

Oct 22, 2026

Details

New companies 1 · Follow-on 0

Stages: Seed 1

Warhound $200M Seed

“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.